title: Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Sugarman
authors.forename: Randy
authors.initials: R
authors.lastname: Stalter
authors.forename: Kevin
authors.initials: K
authors.lastname: Bokoch
authors.forename: Ting-Yuan
authors.initials: TY
authors.lastname: Liu
authors.forename: Deborah
authors.initials: D
authors.lastname: Donnell
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use*; D002681:China; D017326:Clinical Trials, Phase III as Topic; D003376:Counseling; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D066270:Social Capital; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000188:drug therapy*
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine